Racial differences in treatment and survival among Veterans and non-Veterans with stage I NSCLC: An evaluation of Veterans Affairs and SEER-Medicare populations
Cancer Epidemiology, Biomarkers & Prevention Dec 10, 2019
Williams CD, Alpert N, Redding TS, et al. - Because surgery is the preferred treatment for stage I non–small cell lung cancer (NSCLC), with radiation reserved for those not undergoing surgery and prior studies showed lower surgery rates among Blacks with stage I NSCLC than among Whites, researchers used logistic regression and Cox proportional hazards models to explore relationships between race, treatment, and survival. In the Surveillance, Epidemiology, and End Results (SEER)-Medicare database and Veterans Affairs (VA) cancer registry, Black and White men ages ≥ 65 years with stage I NSCLC diagnosed between 2001 and 2009 were identified. According to findings, Blacks were less likely to receive surgical treatment among VA and SEER-Medicare patients. When accounting for treatment, Blacks and Whites had comparable survival outcomes.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries